Trade BioNTech ^BNTX

Analysts' Opinions Are Mixed on These Healthcare Stocks: Dexcom (DXCM), Fractyl Health, Inc. (GUTS) and BioNTech SE (BNTX)

Assessing BioNTech (BNTX) Valuation After Recent Share Price Weakness And Bold $499 Fair Value Narrative

Recent Analysts' Ratings Updates for BioNTech (BNTX) - Daily Political

How Investors May Respond To BioNTech (BNTX) Showcasing Late-Stage Oncology Data At ASCO

BNTX: Leadership Upheaval And Oncology Trial Risks Will Pressure Expectations

BioNTech (NASDAQ:BNTX) Earns Buy Rating from Jefferies Financial Group

BioNTech (NASDAQ:BNTX) Receives "Buy" Rating from Jefferies Financial Group - Stock Observer

Monaco Asset Management SAM Takes Position in BioNTech SE Sponsored ADR $BNTX

BMY: Promising Phase 2 Results for Pumitamig in Lung Cancer Treatment

How Is Pfizer's Stock Performance Compared to Other Healthcare Stocks?

BNP Paribas Financial Markets Raises Stock Holdings in BioNTech SE Sponsored ADR $BNTX

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial | Valuespectrum.com

BioNTech Board Expansion Signals Focus On Oncology Execution And Valuation Gap

BNTX Upgraded by UBS -- Price Target Raised to $135

BioNTech (BNTX) Valuation Check After New Late Stage Oncology Data At 2026 ASCO Meeting

BioNTech (NASDAQ:BNTX) Upgraded at Sanford C. Bernstein - Daily Political

Bernstein starts BioNTech at Market Perform, sees high registration risk

Leonteq Securities AG Invests $2.61 Million in BioNTech SE Sponsored ADR $BNTX

Did Adding Oncology Veterans to the Supervisory Board Just Shift BioNTech's (BNTX) Investment Narrative? - Simply Wall St News

Assessing BioNTech (BNTX) Valuation After Prolonged Share Price Weakness And Loss Making Results

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial

Biontech SE Annual Shareholders Meeting Transcript

BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM

BioNTech comes to Jerusalem: Mayor Moshe Lion announces new mRNA vaccine center

CDC admits Moderna vaccine poses higher risk of heart inflammation

Berenberg Bank Cuts BioNTech (NASDAQ:BNTX) Price Target to $140.00

BioNTech (BNTX) Sees Price Target Adjustment Amid Oncology Pipeline Valuation

Why BioNTech (BNTX) Is Down 5.3% After Authorizing a $1 Billion ADS Buyback and Reaffirming 2026 Guidance

BioNTech: Profit takes precedence over health-and 1,860 employees lose their jobs in Germany - World Socialist Web Site

Wells Fargo & Company Cuts BioNTech (NASDAQ:BNTX) Price Target to $140.00 - Stock Observer

BioNTech (NASDAQ:BNTX) Stock Rating Upgraded by Wall Street Zen

BioNTech (NASDAQ:BNTX) to Buyback $1.00 billion in Shares